In January 2016, Independence Blue Cross and NantHealth announced the nation's first coverage for a whole genome sequencing and proteome molecular diagnostic platform, but it's mostly slipped under the radar since then. What's going on?
Foundation Medicine and ThermoFisher Scientific are big beneficiaries of CMS widening its coverage and making a national coverage decision for next-generation sequencing of metastatic, Stage 3 or 4 and other cancers.
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
Plus, Paul Allen puts $100 million into high-risk biotech research, more California hospitals hit by ransomware and Roger Daltrey pushes 21st Century Cures legislation.
Also, the latest hospital cyber attack (a ransomware attack), Zika gets political, a poll on the best kind of HIMSS keynotes, and the Valeant obituaries are rolling in.
Given Lucier's expertise in M&A, it'll be interesting to see how he expands NuVasive's product portfolio beyond this $380 million acquisition.
Thermo Fisher Scientific (NYSE:TMO) is boosting its supply chain capabilities with its $175 million purchase of chemicals supplier Doe & Ingalls. Durham, North Carolina-based Doe & Ingalls provides specialty chemicals for companies in the life sciences and microelectronics industry. Doe & Ingalls’ 2011 revenue was approximately $110 million. The acquisition by Waltham, Massachusetts-based Thermo Fisher […]
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
Thermo Fisher Scientific Inc. today announced a $2.1 billion acquisition of Sunnyvale, Calif.-based laboratory equipment maker Dionex Corp. Thermo Fisher Scientific Inc. (NYSE:TMO) today announced a deal to take over Sunnyvale Calif.-based Dionex Corp. (NSDQ:DNEX). The Waltham, Mass.-based lab instruments maker plans to pay about $2.1 billion in cash for Dionex, or $118.50 per share, […]
Thermo Fisher Scientific Inc. (NYSE:TMO) agreed to acquire Australian lab supplies provider Lomb Scientific for an undisclosed amount, in a bid to widen its footprint in Asia and the Middle East. Taren Point, New South Wales-based Lomb employs about 100 workers and posted sales of $34 million AUD last year (about $27 million in U.S. […]
Healthcare company chief executives took home the biggest paychecks -- a median of $10 million -- of any industry covered by the recent Wall Street Journal CEO Compensation Study, according to the news organization's Health blog. CEOs from Thermo Fisher Scientific, Boston Scientific and Johnson & Johnson were among the top 20 in the list. Unitedhealth Group CEO Stephen Hemsley got the biggest raise last year.